The purpose of this innovative adaptive phase II trial design is to determine the optimal
combination of hyperbaric oxygen treatment parameters that is most likely to demonstrate
improvement in the outcome of severe TBI patients in a subsequent phase III trial.
Phase:
Phase 2
Details
Lead Sponsor:
Gaylan Rockswold Hennepin Healthcare Research Institute
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS) Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Network